- Bacterial Toxicity Assays
- Enzyme Toxicity Assays
- Tissue Culture Assays
- Western Blots
- Cell-based ELISA
- Receptor Binding Assays
Veterinary Toxicology Testing Market size was valued at USD Bn in 2022, growing at a CAGR of % during the forecast period 2023-2029. Toxicology is study of poisons, including their chemical properties, identification, and biologic effects, and the treatment of disease conditions caused by poisons. Toxicology shares many principles with pharmacology, including the dynamics of absorption, distribution, storage, metabolism, and elimination; mechanisms of action; principles of treatment; and dose-response relationships. Toxicology is a broad division in veterinary medicine. It is important to study the toxic effects of various drugs on in animals. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The Veterinary Toxicology Testing Market report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Global Veterinary Toxicology Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
North America
Fastest Growing Market
Europe
Veterinary Toxicology Testing Market Dynamics
Increase in advanced technologies, rise in R&D activities of toxicology tests, rise in demand for the in vitro toxicology tests over the tradition in vivo tests are the major factors that are fuelling the growth of veterinary toxicology testing market. Furthermore, growing awareness regarding toxic effects on animals, growing veterinary healthcare concern among pet owners, growing adoption of pets propelling the growth of the global veterinary toxicology testing market. On the other hand, stringent regulatory framework, scarcity of testing techniques to detect auto immunity and immune stimulation, technological disadvantages are the factors which are hampering the growth of the veterinary toxicology testing market globally.
North-America Got Significant Share
Veterinary Toxicology Testing Market Regional Analysis
North America expected to be a major market for Global Market owing to factors such as increase in prevalence of adverse effects due to toxicity in animals, well established veterinary healthcare infrastructure, and increase awareness about the animal health among the households and animal owners. Europe is expected to grow at notable rates owing to increase in awareness about the chronic effects of toxicity in animals and rising health concerns on animals. Asia-Pacific region is expected to be a lucrative market due to increase in animal adoptions and entry of market players into the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The veterinary toxicology testing market report provides granular level information about the market size, regional market share, historic market (2018 to 2022), and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Veterinary Toxicology Testing Market Segmentation
By Product
By Technology
- Cellular Imaging Technology
- High Throughput Technology
- Toxic Genomics
- Cell Culture Technology
By End Point
- Skin Sensitization and Irritation
- Cytotoxicity
- Neurotoxicity
- Genotoxicity
- Ocular Toxicity
- Phototoxicity
- Carcinogenicity
- Organ Toxicity
- Dermal Toxicity
By Method
- Ex Vivo Models
- Cellular Assays
- Biochemical Assays
By End User
- Pharmaceutical Industry
- Biopharmaceutical Industry
- Food industry
- Veterinary Pharmaceuticals
- Veterinary Nutrition Industry
Frequently Asked Questions
The veterinary toxicology testing market key players are: Eurofins Scientific (Luxemberg), Wickham Laboratories (U.K), ITR Laboartories (Canada), DuPont (U.K), Bio-Rad Laboratories Inc. (U.S.), Life Technologies Corporation (U.S.), VIRBAC (France), IDEXX Laboratories, Inc. (U.S.)
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Veterinary Toxicology Testing Market Introduction |
| 2.1.Global Veterinary Toxicology Testing Market - Taxonomy |
| 2.2.Global Veterinary Toxicology Testing Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Technology |
| 2.2.3.End Point |
| 2.2.4.Method |
| 2.2.5.Region |
| 3. Global Veterinary Toxicology Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Veterinary Toxicology Testing Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Veterinary Toxicology Testing Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Bacterial Toxicity Assays |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Enzyme Toxicity Assays |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Tissue Culture Assays |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Western Blots |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Cell-based ELISA |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Receptor Binding Assays |
| 5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Veterinary Toxicology Testing Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Cellular Imaging Technology |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. High Throughput Technology |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Toxic Genomics |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Cell Culture Technology |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Veterinary Toxicology Testing Market By End Point, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Skin Sensitization and Irritation |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cytotoxicity |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Neurotoxicity |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Genotoxicity |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Ocular Toxicity |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Phototoxicity |
| 7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Carcinogenicity |
| 7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 7.8. Organ Toxicity |
| 7.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.8.3. Market Opportunity Analysis |
| 7.9. Dermal Toxicity |
| 7.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.9.3. Market Opportunity Analysis |
| 8. Global Veterinary Toxicology Testing Market By Method, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Ex Vivo Models |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cellular Assays |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Biochemical Assays |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Veterinary Toxicology Testing Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Veterinary Toxicology Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Bacterial Toxicity Assays |
| 10.1.2.Enzyme Toxicity Assays |
| 10.1.3.Tissue Culture Assays |
| 10.1.4.Western Blots |
| 10.1.5.Cell-based ELISA |
| 10.1.6.Receptor Binding Assays |
| 10.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cellular Imaging Technology |
| 10.2.2.High Throughput Technology |
| 10.2.3.Toxic Genomics |
| 10.2.4.Cell Culture Technology |
| 10.3. End Point Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Skin Sensitization and Irritation |
| 10.3.2.Cytotoxicity |
| 10.3.3.Neurotoxicity |
| 10.3.4.Genotoxicity |
| 10.3.5.Ocular Toxicity |
| 10.3.6.Phototoxicity |
| 10.3.7.Carcinogenicity |
| 10.3.8.Organ Toxicity |
| 10.3.9.Dermal Toxicity |
| 10.4. Method Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Ex Vivo Models |
| 10.4.2.Cellular Assays |
| 10.4.3.Biochemical Assays |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Veterinary Toxicology Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Bacterial Toxicity Assays |
| 11.1.2.Enzyme Toxicity Assays |
| 11.1.3.Tissue Culture Assays |
| 11.1.4.Western Blots |
| 11.1.5.Cell-based ELISA |
| 11.1.6.Receptor Binding Assays |
| 11.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cellular Imaging Technology |
| 11.2.2.High Throughput Technology |
| 11.2.3.Toxic Genomics |
| 11.2.4.Cell Culture Technology |
| 11.3. End Point Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Skin Sensitization and Irritation |
| 11.3.2.Cytotoxicity |
| 11.3.3.Neurotoxicity |
| 11.3.4.Genotoxicity |
| 11.3.5.Ocular Toxicity |
| 11.3.6.Phototoxicity |
| 11.3.7.Carcinogenicity |
| 11.3.8.Organ Toxicity |
| 11.3.9.Dermal Toxicity |
| 11.4. Method Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Ex Vivo Models |
| 11.4.2.Cellular Assays |
| 11.4.3.Biochemical Assays |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 11.5.7. |
| 12. Asia Pacific (APAC) Veterinary Toxicology Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Bacterial Toxicity Assays |
| 12.1.2.Enzyme Toxicity Assays |
| 12.1.3.Tissue Culture Assays |
| 12.1.4.Western Blots |
| 12.1.5.Cell-based ELISA |
| 12.1.6.Receptor Binding Assays |
| 12.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cellular Imaging Technology |
| 12.2.2.High Throughput Technology |
| 12.2.3.Toxic Genomics |
| 12.2.4.Cell Culture Technology |
| 12.3. End Point Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Skin Sensitization and Irritation |
| 12.3.2.Cytotoxicity |
| 12.3.3.Neurotoxicity |
| 12.3.4.Genotoxicity |
| 12.3.5.Ocular Toxicity |
| 12.3.6.Phototoxicity |
| 12.3.7.Carcinogenicity |
| 12.3.8.Organ Toxicity |
| 12.3.9.Dermal Toxicity |
| 12.4. Method Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Ex Vivo Models |
| 12.4.2.Cellular Assays |
| 12.4.3.Biochemical Assays |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Veterinary Toxicology Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Bacterial Toxicity Assays |
| 13.1.2.Enzyme Toxicity Assays |
| 13.1.3.Tissue Culture Assays |
| 13.1.4.Western Blots |
| 13.1.5.Cell-based ELISA |
| 13.1.6.Receptor Binding Assays |
| 13.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cellular Imaging Technology |
| 13.2.2.High Throughput Technology |
| 13.2.3.Toxic Genomics |
| 13.2.4.Cell Culture Technology |
| 13.3. End Point Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Skin Sensitization and Irritation |
| 13.3.2.Cytotoxicity |
| 13.3.3.Neurotoxicity |
| 13.3.4.Genotoxicity |
| 13.3.5.Ocular Toxicity |
| 13.3.6.Phototoxicity |
| 13.3.7.Carcinogenicity |
| 13.3.8.Organ Toxicity |
| 13.3.9.Dermal Toxicity |
| 13.4. Method Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Ex Vivo Models |
| 13.4.2.Cellular Assays |
| 13.4.3.Biochemical Assays |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Veterinary Toxicology Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Bacterial Toxicity Assays |
| 14.1.2.Enzyme Toxicity Assays |
| 14.1.3.Tissue Culture Assays |
| 14.1.4.Western Blots |
| 14.1.5.Cell-based ELISA |
| 14.1.6.Receptor Binding Assays |
| 14.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Cellular Imaging Technology |
| 14.2.2.High Throughput Technology |
| 14.2.3.Toxic Genomics |
| 14.2.4.Cell Culture Technology |
| 14.3. End Point Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Skin Sensitization and Irritation |
| 14.3.2.Cytotoxicity |
| 14.3.3.Neurotoxicity |
| 14.3.4.Genotoxicity |
| 14.3.5.Ocular Toxicity |
| 14.3.6.Phototoxicity |
| 14.3.7.Carcinogenicity |
| 14.3.8.Organ Toxicity |
| 14.3.9.Dermal Toxicity |
| 14.4. Method Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Ex Vivo Models |
| 14.4.2.Cellular Assays |
| 14.4.3.Biochemical Assays |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1. Eurofins Scientific (Luxemberg) |
| 15.2.2. Wickham Laboratories (U.K) |
| 15.2.3. ITR Laboartories (Canada) |
| 15.2.4. DuPont (U.K) |
| 15.2.5. Bio-Rad Laboratories Inc. (U.S.) |
| 15.2.6. Life Technologies Corporation (U.S.) |
| 15.2.7. VIRBAC (France) |
| 15.2.8. IDEXX Laboratories, Inc. (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Eurofins Scientific (Luxemberg)
- Wickham Laboratories (U.K)
- ITR Laboartories (Canada)
- DuPont (U.K)
- Bio-Rad Laboratories Inc. (U.S.)
- Life Technologies Corporation (U.S.)
- VIRBAC (France)
- IDEXX Laboratories, Inc. (U.S.)